Development of Immunoassays for Ginsenosides in Ginseng
-
Published:2020
Issue:
Volume:
Page:383-394
-
ISSN:
-
Container-title:Medicinal Plants: Biodiversity, Sustainable Utilization and Conservation
-
language:
-
Short-container-title:
Publisher
Springer Singapore
Reference28 articles.
1. Fukuda N, Tanaka H, Shoyama Y (2000a) Formation of monoclonal antibody against a major ginseng component, ginsenoside Rg1 and its characterization. Cytotechnology 34:197–204
2. Fukuda N, Tanaka H, Shoyama Y (2000b) Isolation of the pharmacologically active saponin ginsenoside Rb1 from ginseng by immunoaffinity column chromatography. J Nat Prod 63:283–285
3. Fukuda N, Tanaka H, Shoyama Y (2000c) Application of ELISA, Western blotting and immunoaffinity concentration for survey of ginsenosides in crude drugs of Panax species and traditional Chinese herbal medicines. Analyst 125:1425–1429
4. Fukuda N, Tanaka H, Shoyama Y (2001) Double staining of ginsenosides by Western blotting using anti-ginsenoside Rb1 and Rg1 monoclonal antibodies. Biol Pharm Bull 24:1157–1160
5. Ishiyama M, Shoyama Y, Murakami H, Shinohara H (1996) Production of monoclonal antibodies and development of an ELISA for solamargine. Cytotechnology 18:153–158